Clinical benefit and safety associated with mRNA vaccines for advanced solid tumors: A meta‐analysis

Tumor mRNA vaccines have been developed for over 20 years. Whether mRNA vaccines could promote a clinical benefit to advanced cancer patients is highly unknown. PubMed and Embase were retrieved from January 1, 2000 to January 4, 2023. Random effects models were employed. Clinical benefit (objective...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Tian‐yi, Xu, Hang, Zheng, Xiao‐nan, Xiong, Xing‐yu, Zhang, Shi‐yu, Yi, Xian‐yanling, Li, Jin, Wei, Qiang, Ai, Jian‐zhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10353527/
https://www.ncbi.nlm.nih.gov/pubmed/37470066
http://dx.doi.org/10.1002/mco2.286

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10353527/
https://www.ncbi.nlm.nih.gov/pubmed/37470066
http://dx.doi.org/10.1002/mco2.286

Ejemplares similares